Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sandra Phillips, Ravi Jagatia & Shilpa Chokshi. (2022) Novel therapeutic strategies for chronic hepatitis B. Virulence 13:1, pages 1111-1132.
Read now
Read now
Samvel Sirakanyan, Erik Arabyan, Astghik Hakobyan, Tamara Hakobyan, Garri Chilingaryan, Harutyun Sahakyan, Arsen Sargsyan, Grigor Arakelov, Karen Nazaryan, Roza Izmailyan, Liana Abroyan, Zaven Karalyan, Elina Arakelova, Elmira Hakobyan, Anush Hovakimyan, Andre Serobian, Marco Neves, João Ferreira, Fernando Ferreira & Hovakim Zakaryan. (2021) A new microtubule-stabilizing agent shows potent antiviral effects against African swine fever virus with no cytotoxicity. Emerging Microbes & Infections 10:1, pages 783-796.
Read now
Read now
Madia Lozupone, Vincenzo Solfrizzi, Francesca D’Urso, Ilaria Di Gioia, Rodolfo Sardone, Vittorio Dibello, Roberta Stallone, Angelo Liguori, Chiara Ciritella, Antonio Daniele, Antonello Bellomo, Davide Seripa & Francesco Panza. (2020) Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs. Expert Opinion on Emerging Drugs 25:3, pages 319-335.
Read now
Read now
Daren R. Ure, Daniel J. Trepanier, Patrick R. Mayo & Robert T. Foster. (2020) Cyclophilin inhibition as a potential treatment for nonalcoholic steatohepatitis (NASH). Expert Opinion on Investigational Drugs 29:2, pages 163-178.
Read now
Read now
Articles from other publishers (20)
Alan Rawls, Bridget K. Diviak, Cameron I. Smith, Grant W. Severson, Sofia A. Acosta & Jeanne Wilson-Rawls. (2023) Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies. Biomolecules 13:10, pages 1536.
Crossref
Crossref
Yifan Xing, Ran Chen, Feng Li, Bin Xu, Lin Han, Chaolun Liu, Yimin Tong, Yaming Jiu, Jin Zhong & Guo-Chun Zhou. (2023) Discovery of a fused bicyclic derivative of 4-hydroxypyrrolidine and imidazolidinone as a new anti-HCV agent. Virology 586, pages 91-104.
Crossref
Crossref
Huihui Yang, Weiwei Yao & Jinfei Yang. (2023) Overview of the development of HBV small molecule inhibitors. European Journal of Medicinal Chemistry 249, pages 115128.
Crossref
Crossref
Ayushi Chaurasiya, Geeta Kumari, Swati Garg, Rumaisha Shoaib, Zille Anam, Nishant Joshi, Jyoti Kumari, Jhalak Singhal, Niharika Singh, Shikha Kaushik, Amandeep Kaur Kahlon, Neha Dubey, Mukesh Kumar Maurya, Pallavi Srivastava, Manisha Marothia, Prerna Joshi, Kanika Gupta, Savita Saini, Gobardhan Das, Souvik Bhattacharjee, Shailja Singh & Anand Ranganathan. (2022) Targeting Artemisinin-Resistant Malaria by Repurposing the Anti-Hepatitis C Virus Drug Alisporivir. Antimicrobial Agents and Chemotherapy 66:12.
Crossref
Crossref
Yaru Wu, Zhenling Ma, Yanyan Zhang, Min Zhang, Xixi Shi, Menghao Zhang, Wenwen Zhang & Wei Liu. (2022) The role of cyclophilins in viral infection and the immune response. Journal of Infection 85:4, pages 365-373.
Crossref
Crossref
Giuseppe Barisano, Axel Montagne, Kassandra Kisler, Julie A. Schneider, Joanna M. Wardlaw & Berislav V. Zlokovic. (2022) Blood–brain barrier link to human cognitive impairment and Alzheimer’s disease. Nature Cardiovascular Research 1:2, pages 108-115.
Crossref
Crossref
Helga Rübsamen‐Schaeff & Helmut BuschmannMichael J. Sofia. 2022. New Drug Development for Known and Emerging Viruses. New Drug Development for Known and Emerging Viruses
13
57
.
Carla E. Gallardo-Flores & Che C. Colpitts. (2021) Cyclophilins and Their Roles in Hepatitis C Virus and Flavivirus Infections: Perspectives for Novel Antiviral Approaches. Pathogens 10:7, pages 902.
Crossref
Crossref
Axel Montagne, Angeliki M. Nikolakopoulou, Mikko T. Huuskonen, Abhay P. Sagare, Erica J. Lawson, Divna Lazic, Sanket V. Rege, Alexandra Grond, Edward Zuniga, Samuel R. Barnes, Jacob Prince, Meghana Sagare, Ching-Ju Hsu, Mary J. LaDu, Russell E. Jacobs & Berislav V. Zlokovic. (2021) APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer’s mice via cyclophilin A independently of amyloid-β. Nature Aging 1:6, pages 506-520.
Crossref
Crossref
Xinlei Li & Tao Peng. (2021) Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery. Frontiers in Pharmacology 12.
Crossref
Crossref
Alsu Z. Malikova, Anastasia S. Shcherbakova, Konstantin A. Konduktorov, Anastasia S. Zemskaya, Alexandra A. Dalina, Vladimir I. Popenko, Olga G. Leonova, Alexei V. Morozov, Nikolay N. Kurochkin, Olga A. Smirnova, Sergey N. Kochetkov & Maxim V. Kozlov. (2021) Pre-Senescence Induction in Hepatoma Cells Favors Hepatitis C Virus Replication and Can Be Used in Exploring Antiviral Potential of Histone Deacetylase Inhibitors. International Journal of Molecular Sciences 22:9, pages 4559.
Crossref
Crossref
Gillian Coughlan, Ryan Larsen, Min Kim, David White, Rachel Gillings, Michael Irvine, Andrew Scholey, Neal Cohen, Cristina Legido-Quigley, Michael Hornberger & Anne-Marie Minihane. (2021)
APOE
ε4 alters associations between docosahexaenoic acid and preclinical markers of Alzheimer’s disease
. Brain Communications 3:2.
Crossref
Crossref
Angeliki Maria Nikolakopoulou, Yaoming Wang, Qingyi Ma, Abhay P. Sagare, Axel Montagne, Mikko T. Huuskonen, Sanket V. Rege, Kassandra Kisler, Zhonghua Dai, Jakob Körbelin, Joachim Herz, Zhen Zhao & Berislav V. Zlokovic. (2021) Endothelial LRP1 protects against neurodegeneration by blocking cyclophilin A. Journal of Experimental Medicine 218:4.
Crossref
Crossref
G. V. Kochneva, M. Yu. Kartashov, E. I. Krivosheina, A. I. Kuznetsov, E. V. Chub, G. F. Sivolobova & S. V. Netesov. (2021) On the Possibility of Eradicating Hepatitis C in Russia. Molecular Genetics, Microbiology and Virology 36:1, pages 27-38.
Crossref
Crossref
G.V. Kochneva, M.Yu. Kartashov, E.I. Krivosheina, A.I. Kuznetsov, E.V. Chub, G.F. Sivolobova & S.V. Netesov. (2021) On the possibility of eradicating hepatitis C in Russia. Molecular Genetics Microbiology and Virology (Russian version) 39:1, pages 31.
Crossref
Crossref
Janet L. Paulsen, Haoyu S. Yu, Dan Sindhikara, Lingle Wang, Todd Appleby, Armando G. Villaseñor, Uli Schmitz & Devleena Shivakumar. (2020) Evaluation of Free Energy Calculations for the Prioritization of Macrocycle Synthesis. Journal of Chemical Information and Modeling 60:7, pages 3489-3498.
Crossref
Crossref
Min Sun, Hankun Hu, Leming Sun & Zhen Fan. (2020) The application of biomacromolecules to improve oral absorption by enhanced intestinal permeability: A mini-review. Chinese Chemical Letters 31:7, pages 1729-1736.
Crossref
Crossref
Axel Montagne, Daniel A. Nation, Abhay P. Sagare, Giuseppe Barisano, Melanie D. Sweeney, Ararat Chakhoyan, Maricarmen Pachicano, Elizabeth Joe, Amy R. Nelson, Lina M. D’Orazio, David P. Buennagel, Michael G. Harrington, Tammie L. S. Benzinger, Anne M. Fagan, John M. Ringman, Lon S. Schneider, John C. Morris, Eric M. Reiman, Richard J. Caselli, Helena C. Chui, Julia TCW, Yining Chen, Judy Pa, Peter S. Conti, Meng Law, Arthur W. Toga & Berislav V. Zlokovic. (2020) APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline. Nature 581:7806, pages 71-76.
Crossref
Crossref
Emese Tóth, József Maléth, Noémi Závogyán, Júlia Fanczal, Anna Grassalkovich, Réka Erdős, Petra Pallagi, Gergő Horváth, László Tretter, Emese Réka Bálint, Zoltán RakonczayJrJr, Viktória Venglovecz & Péter Hegyi. (2019)
Novel mitochondrial transition pore inhibitor
N
‐methyl‐4‐isoleucine cyclosporin is a new therapeutic option in acute pancreatitis
. The Journal of Physiology 597:24, pages 5879-5898.
Crossref
Crossref
Joseph Kuo, Michael Bobardt, Udayan Chatterji, Patrick R. Mayo, Daniel J. Trepanier, Robert T. Foster, Philippe Gallay & Daren R. Ure. (2019) A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models. Journal of Pharmacology and Experimental Therapeutics 371:2, pages 231-241.
Crossref
Crossref